Isolated Atrioventricular Block in the Fetus: A Retrospective, Multinational, Multicenter Study of 175 Patients
Isolated congenital complete atrioventricular block in the fetus is a rare but potentially lethal condition, most frequently associated with transplacental passage of maternal anti-Ro/SSA autoantibodies. With the assumption that this triggers an inflammatory reaction and subsequent fibrosis in the atrioventricular node, transplacental steroid treatment has been used with the aim to mitigate cardiac damage, but the effect of steroid treatment on outcome is still unclear. In this retrospective multicenter study of 175 fetuses with second-or third-degree atrioventricular block, 38% were treated with fluorinated steroids. Ninety-one percent were alive at birth, and survival in the neonatal period was 93%, without any difference between steroid-treated and untreated patients. A gestational age Ͻ20 weeks, a ventricular rate Յ50 bpm, the presence of fetal hydrops, and impaired left ventricular function at diagnosis were associated with an increased risk of death. The presence of Ն1 of these risk factors was associated with a 10-fold increase in mortality before birth and a 6-fold increase in the neonatal period independently of treatment. Except for a slightly lower gestational age at diagnosis in treated than untreated patients, risk factors were equally distributed between groups. Reversion of incomplete atrioventricular block was seen in 5 steroid-treated patients, but only 2 of them remained in sinus rhythm at 1 and 2.7 years of age. Our results do not support universal treatment with steroids for antibody-exposed fetuses with complete atrioventricular block, but because of the retrospective design, we cannot rule out a possibly beneficial, or even harmful, effect of steroids. See p 1919. The cardiac manifestations of neonatal lupus include advanced conduction disease and rarely an isolated cardiomyopathy. This study, which included 325 offspring exposed to maternal anti-SSA/Ro antibodies with cardiac neonatal lupus, was used to determine the mortality, morbidity, and associated risk factors in a multi-racial/ethnic US-based registry. The case fatality rate was 17.5%. A third of the cases died in utero. The cumulative probability of survival at 10 years for a child born alive was 86% (most dying within a year of birth). Fetal echocardiographic risk factors associated with a statistically significant increase in mortality in a multivariate analysis included hydrops, endocardial fibroelastosis, an earlier diagnosis of cardiac neonatal lupus, and a lower ventricular rate. Overall, isolated advanced heart block was associated with a 7.8% case fatality rate, whereas the concomitant presence of dilated cardiomyopathy or endocardial fibroelastosis more than quadrupled the case fatality rate. There was a significantly higher case fatality rate in minorities compared with whites, who were at a lower risk of hydrops and endocardial fibroelastosis. Pacing was required in 70% by 10 years, and 4 children underwent cardiac transplantation. Data from this cohort reveal that nearly one fifth of fetuses who develop cardiac neonatal lupus die of complications predicted by echocardiographic abnormalities consistent with antibody-associated disease beyond the atrioventricular node. See p 1927.
Transcoronary Concentration Gradients of Circulating MicroRNAs
MicroRNAs (miRNAs) are short, noncoding RNAs that control gene expression on a posttranslational level. Recent studies show that miRNA can be detected in circulating blood, and selected miRNAs have been shown to be elevated in the blood after acute myocardial infarction. Here, we demonstrate that muscle-enriched miR-499 and miR-133a are released from the heart into the coronary circulation on myocardial injury and that this release closely correlates with the extent of myocardial injury. In contrast, the endothelial cellenriched miR-126 is consumed during transcoronary passage in patients with evidence of myocardial injury. These data suggest a differential regulation of muscle versus vascular miRNAs across the coronary circulation. Because muscle-related miRNAs closely correlate with the extent of myocardial injury, future studies should evaluate their usefulness as biomarkers for cardiac injury. See p 1936.
Effects of a Novel Aldosterone Synthase Inhibitor for Treatment of Primary Hypertension: Results of a Randomized, Double-Blind, Placebo-and Active-Controlled Phase 2 Trial
A growing body of literature links aldosterone to the development and/or progression of a variety of cardiovascular disease processes, including endothelial dysfunction, hypertension, ventricular remodeling, and congestive heart failure. Blockade of the mineralocorticoid receptor with antagonists such as spironolactone has shown benefit in blunting or reversing many of the unfavorable effects attributed to aldosterone. An alternative approach to blocking the effects of aldosterone is to prevent its production by inhibiting aldosterone synthase. The present findings indicate that inhibition of aldosterone synthase with the novel compound LCI699 significantly lowers blood pressure in patients with mild to moderate hypertension. The compound was safe and well tolerated. Aldosterone synthase inhibition with LCI699 was accompanied by suppression of adrenocorticotropic hormone-stimulated release of cortisol in a proportion of subjects, indicating partial inhibition of 11-␤-hydroxylase. Overall, the present results indicate that aldosterone synthase inhibition may represent a novel and effective approach to lowering high blood pressure. Additional studies are needed to determine whether there is differential antihypertensive and/or cardiovascular benefit of suppressing aldosterone production compared with blocking activation of the mineralocorticoid receptor. Such testing will need to include elucidation of the effects of partial suppression of cortisol synthesis. See p 1945.
Association of Physical Activity With Vascular Endothelial Function and Intima-Media Thickness: A Longitudinal Study in Adolescents
The development and progression of subclinical atherosclerosis in adolescence are associated with functional and structural changes of the arteries, including impairment of the arterial vasodilatory function and thickening of the arterial wall. Flow-mediated dilatation of the brachial artery, assessed noninvasively by ultrasound, is a widely used marker of systemic arterial endothelial function. Although the carotid artery has commonly been the target for ultrasonic assessment of early structural changes, the earliest morphological alterations emerge in the abdominal aorta. Intima-media thickness of the abdominal aorta may therefore be a better surrogate marker of atherosclerosis than carotid intima-media thickness especially at young age. Physical activity has a beneficial effect on vascular function and structure by enhancing endothelial function and decreasing the progression of carotid intima-media thickness. To date, data on the effect of physical activity on vascular function and structure in adolescents are scarce and longitudinal studies are lacking. Our study shows the favorable effect of leisure-time physical activity on flowmediated dilatation and intima-media thickness in nearly 500 adolescents studied repeatedly at 13, 15, and 17 years of age. Importantly, even a moderate increase in physical activity among those who were sedentary was related to a decreased progression of intima-media thickness. These results emphasize the potential of promoting physical activity, especially in inactive adolescents, to support cardiovascular health. Clinicians should encourage physical activity among adolescents, and enjoyable ways to increase physical activity should be paid attention to, especially for those who are sedentary. See p 1956.
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